Literature DB >> 25023276

Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.

Kathryn C Fitzgerald1, Éilis J O'Reilly2, Guido J Falcone3, Marjorie L McCullough4, Yikyung Park5, Laurence N Kolonel6, Alberto Ascherio7.   

Abstract

IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a severe progressive disease that cannot be prevented or cured. Diet-derived long-chain polyunsaturated fatty acids (PUFAs) are incorporated in brain lipids and modulate oxidative and inflammatory processes and could thus affect ALS risk and progression.
OBJECTIVE: To examine the association between ω-6 and ω-3 PUFA consumption and ALS risk. DESIGN, SETTING, AND PARTICIPANTS: Longitudinal analyses based on 1,002,082 participants (479,114 women and 522,968 men) in 5 prospective cohorts: the National Institutes of Health-AARP Diet and Health Study, the Cancer Prevention Study II Nutrition Cohort, the Health Professionals Follow-up Study, the Multiethnic Cohort Study, and the Nurses' Health Study. Diet was assessed via food frequency questionnaire developed or modified for each cohort. Participants were categorized into cohort-specific quintiles of intake of energy-adjusted dietary variables. MAIN OUTCOMES AND MEASURES: Cohort-specific multivariable-adjusted risk ratios (RRs) of ALS incidence or death estimated by Cox proportional hazards regression and pooled using random-effects methods.
RESULTS: A total of 995 ALS cases were documented during the follow-up. A greater ω-3 PUFA intake was associated with a reduced risk for ALS. The pooled, multivariable-adjusted RR for the highest to the lowest quintile was 0.66 (95% CI, 0.53-0.81; P < .001 for trend). Consumption of both α-linolenic acid (RR, 0.73; 95% CI, 0.59-0.89; P = .003 for trend) and marine ω-3 PUFAs (RR, 0.84; 95% CI, 0.65-1.08; P = .03 for trend) contributed to this inverse association. Intakes of ω-6 PUFA were not associated with ALS risk. CONCLUSIONS AND RELEVANCE: Consumption of foods high in ω-3 PUFAs may help prevent or delay the onset of ALS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023276      PMCID: PMC4160351          DOI: 10.1001/jamaneurol.2014.1214

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  49 in total

1.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

2.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

Review 3.  Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.

Authors:  Laura Ferraiuolo; Janine Kirby; Andrew J Grierson; Michael Sendtner; Pamela J Shaw
Journal:  Nat Rev Neurol       Date:  2011-11       Impact factor: 42.937

4.  Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.

Authors:  Hao Wang; Éilis J O'Reilly; Marc G Weisskopf; Giancarlo Logroscino; Marjorie L McCullough; Arthur Schatzkin; Laurence N Kolonel; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2011-02-18       Impact factor: 4.897

5.  Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts.

Authors:  Hao Wang; Éilis J O'Reilly; Marc G Weisskopf; Giancarlo Logroscino; Marji L McCullough; Michael J Thun; Arthur Schatzkin; Laurence N Kolonel; Alberto Ascherio
Journal:  Arch Neurol       Date:  2011-02

6.  Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats.

Authors:  Fei Gao; Dale Kiesewetter; Lisa Chang; Kaizong Ma; Jane M Bell; Stanley I Rapoport; Miki Igarashi
Journal:  J Lipid Res       Date:  2008-12-11       Impact factor: 5.922

7.  Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice.

Authors:  Haiyan Zhu; Chaonan Fan; Feng Xu; Chunyu Tian; Feng Zhang; Kemin Qi
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

Review 8.  NF-kappaB in the nervous system.

Authors:  Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

Review 9.  Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease.

Authors:  Nicolas G Bazan
Journal:  J Lipid Res       Date:  2008-11-18       Impact factor: 5.922

Review 10.  Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection.

Authors:  Wenting Zhang; Peiying Li; Xiaoming Hu; Feng Zhang; Jun Chen; Yanqin Gao
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01
View more
  36 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. study.

Authors:  Angeline S Andrew; Katie M O'Brien; Brian P Jackson; Dale P Sandler; Wendy E Kaye; Laurie Wagner; Elijah W Stommel; D Kevin Horton; Paul Mehta; Clarice R Weinberg
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-04-24       Impact factor: 4.092

Review 3.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

4.  Toenail mercury Levels are associated with amyotrophic lateral sclerosis risk.

Authors:  Angeline S Andrew; Celia Y Chen; Tracie A Caller; Rup Tandan; Patricia L Henegan; Brian P Jackson; Brenda P Hall; Walter G Bradley; Elijah W Stommel
Journal:  Muscle Nerve       Date:  2018-01-04       Impact factor: 3.217

5.  A Docosahexaenoic Acid-Derived Pro-resolving Agent, Maresin 1, Protects Motor Neuron Cells Death.

Authors:  Kazuki Ohuchi; Yoko Ono; Mina Joho; Kazuhiro Tsuruma; Shiho Ogami; Shinsaku Yamane; Michinori Funato; Hideo Kaneko; Shinsuke Nakamura; Hideaki Hara; Masamitsu Shimazawa
Journal:  Neurochem Res       Date:  2018-05-24       Impact factor: 3.996

6.  Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies.

Authors:  Elinor Fondell; É Ilis J O'Reilly; Kathryn C Fitzgerald; Guido J Falcone; Laurence N Kolonel; Yikyung Park; Susan M Gapstur; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-03-30       Impact factor: 4.092

7.  Multiomic blood correlates of genetic risk identify presymptomatic disease alterations.

Authors:  Michael Wainberg; Andrew T Magis; John C Earls; Jennifer C Lovejoy; Nasa Sinnott-Armstrong; Gilbert S Omenn; Leroy Hood; Nathan D Price
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

Review 8.  [Nutrition and dietary supplements in neurological diseases].

Authors:  F Erbguth; H Himmerich
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

9.  Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.

Authors:  Yvonne L Eaglehouse; Evelyn O Talbott; Yuefang Chang; Lewis H Kuller
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

Review 10.  Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.

Authors:  Kaitlin A Hagan; Kassandra L Munger; Alberto Ascherio; Francine Grodstein
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.